Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Naproxen sodium + codeine is a fixed-dose combination of two analgesic agents used for the relief of moderate to moderately severe pain. Naproxen sodium is a nonsteroidal anti-inflammatory drug (NSAID) that works primarily by inhibiting prostaglandin synthesis, thereby reducing inflammation, pain, and fever[5][4]. Codeine is an opioid analgesic that acts as an agonist at opioid receptors in the central nervous system to provide pain relief[6]. The combination provides additive analgesic effects from both components and may be used when monotherapy with either agent is insufficient[2]. This combination does not demonstrate synergistic interaction but rather additive efficacy and increased risk of adverse effects associated with opioids such as nausea or drowsiness[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Naproxen sodium + codeine.